| 产品描述: | XMU-MP-9 is a bifunctional compound that binds to the C2 domain of Nedd4-1 and the allosteric site of K-Ras. XMU-MP-9 enhances the interaction between Nedd4-1 and K-Ras, induces conformational changes in the Nedd4-1/K-Ras complex, promotes the ubiquitination and degradation of multiple K-Ras mutants, and inhibits the proliferation of cells carrying K-Ras mutants. XMU-MP-9 can be used for the study of colon, lung and pancreatic cancer. |
| 体外研究: |
XMU-MP-9 (40-80 mg/kg;尾静脉注射;每日一次或两次) 可抑制裸鼠体内 SW620 异种移植肿瘤的生长,降低 K-RasG12V 水平和下游信号传导 (p-B-Raf、p-MEK)[1]。 |
| 体内研究: |
XMU-MP-9 (10 μM;48 h) 在 SW620 细胞中通过溶酶体途径促进 K-RasG12V 的降解。 XMU-MP-9 (2-20 μM) 在 2-D 培养中抑制含 K-Ras 突变体的癌细胞 (SW620、AsPC-1 等) 增殖。 |
| 保存条件: |
-80°C 12个月; -20°C 6个月,干燥, 避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.592 ml |
12.959 ml |
25.917 ml |
| 5 mM |
0.518 ml |
2.592 ml |
5.183 ml |
| 10 mM |
0.259 ml |
1.296 ml |
2.592 ml |
| 50 mM |
0.052 ml |
0.259 ml |
0.518 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |